Mqs Management LLC Eli Lilly & CO Transaction History

Mqs Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $102,450 - $137,064	-173 Reduced 24.26%	540 $420,000
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $374,460 - $441,439	713 New	713 $415,000
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $188,863 - $221,810	-608 Reduced 25.75%	1,753 $602,000
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $759,179 - $884,595	2,361 New	2,361 $863,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mqs Management LLC with notifications on news.